SAN CARLOS, Calif., Jan 02, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- Nektar Therapeutics' (Nasdaq: NKTR) President and CEO Howard W. Robin will deliver the corporate presentation at the upcoming JPMorgan 26th Annual Healthcare Conference at the Westin St. Francis Hotel in San Francisco, California on Tuesday, January 8, 2008, at 4:30 p.m. Pacific Time.
The presentation will be accessible through a live audio and slideshow webcast through a link posted on the Investor Relations, Events Calendar section of the Nektar website: http://www.nektar.com. This Webcast will be available for replay until January 22, 2008.
Nektar Therapeutics is a biopharmaceutical company that develops and enables differentiated therapeutics with its industry-leading PEGylation and pulmonary drug development platforms. Nektar PEGylation and pulmonary technology, expertise, and manufacturing capabilities have enabled ten approved products for partners, which include the world's leading pharmaceutical and biotechnology companies. Nektar also develops its own products by applying its PEGylation and pulmonary technology platforms to existing medicines with the objective to enhance performance, such as improving efficacy, safety and compliance.
Nektar Therapeutics
201 Industrial Road
San Carlos, CA 94070
650-631-3100 Phone 650-631-3150 Fax
SOURCE Nektar Therapeutics
http://www.nektar.com
Copyright (C) 2008 PR Newswire. All rights reserved
News Provided by COMTEX